Sugar-sweetened beverages and colorectal cancer risk in the California Teachers Study


Autoři: Lorena S. Pacheco aff001;  Cheryl A. M. Anderson aff001;  James V. Lacey, Jr. aff003;  Edward L. Giovannucci aff004;  Hector Lemus aff002;  Maria Rosario G. Araneta aff001;  Dorothy D. Sears aff001;  Gregory A. Talavera aff002;  Maria Elena Martinez aff001
Působiště autorů: Department of Family Medicine and Public Health, School of Medicine, University of California San Diego, La Jolla, California, United States of America aff001;  School of Public Health, San Diego State University, San Diego, California, United States of America aff002;  Division of Health Analytics, Department of Computational and Quantitative Medicine, City of Hope, Duarte, California, United States of America aff003;  Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America aff004;  Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America aff005;  College of Health Solution, Arizona State University, Phoenix, Arizona, United States of America aff006;  Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America aff007
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
doi: 10.1371/journal.pone.0223638

Souhrn

Background

The association between sugar-sweetened beverage (SSB) consumption and colorectal cancer (CRC) risk remains unclear and published data are limited.

Methods

The analytic cohort included 99,798 women, free of cancer at baseline, from the California Teachers Study, a longitudinal cohort comprised of 133,477 female teachers and administrators who were active or recently retired members of the California State Teachers Retirement System in 1995. SSB consumption constituted caloric soft drinks, sweetened bottled waters and teas, and fruit drinks, derived from a self-administered food frequency questionnaire. Consumption was divided into four categories: Rare or never, >rare/never to <1 serving/week, ≥1 serving/week to <1 serving/day, and ≥1 serving/day. CRC endpoints were based on annual linkage with California Cancer Registry, defined as first diagnosis of CRC, and classified following the Surveillance, Epidemiology, and End Results Program coding system. Multivariable-adjusted Cox proportional hazards models were used to generate hazard ratios (HR) and 95% confidence intervals (CI) for assessing the association between SSB consumption and incident CRC.

Results

A total of 1,318 incident CRC cases were identified over 20 years of follow-up (54.5% proximal colon and 45.5% distal colorectum). Compared with rare/never consumers, the multivariable-adjusted HRs (95% CI) were 1.14 (0.86, 1.53) for total CRC; 1.11 (0.73, 1.68) for proximal colon; and 1.22 (0.80, 1.86) for distal colorectum cancers among women consuming ≥ 1 serving/day of SSBs.

Conclusion

SSBs were not significantly associated with CRC risk. The biological effects of high SSB consumption make it important to continue to evaluate whether SSBs are associated with CRC. Additionally, future studies should further assess SSBs in large, racial/ethnically diverse cohorts of males and females, and, if feasible, address changes in SSB consumption over time.

Klíčová slova:

Beverages – California – Cancer detection and diagnosis – Colon – Colorectal cancer – Meat – Tea – Teachers


Zdroje

1. Aicr and WCRF, “Diet, nutrition, physical activity and colorectal cancer.”

2. Siegel R. L. et al., “Colorectal cancer statistics, 2017,” CA. Cancer J. Clin., vol. 67, no. 3, pp. 177–193, May 2017.

3. Arnold M., Sierra M. S., Laversanne M., Soerjomataram I., Jemal A., and Bray F., “Global patterns and trends in colorectal cancer incidence and mortality,” BMJ, no. 66, pp. 683–691, 2017.

4. A. T. Chan and E. L. Giovannucci, “Primary Prevention of Colorectal Cancer,” 2010.

5. Y. Ma et al., “Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies.”

6. Boyle T., Keegel T., Bull F., Heyworth J., and Fritschi L., “Physical Activity and Risks of Proximal and Distal Colon Cancers: A Systematic Review and Meta-analysis,” JNCI J. Natl. Cancer Inst., vol. 104, no. 20, pp. 1548–1561, Oct. 2012.

7. Samad A. K. A., Taylor R. S., Marshall T., and Chapman M. A. S., “A meta-analysis of the association of physical activity with reduced risk of colorectal cancer,” Color. Dis., vol. 7, no. 3, pp. 204–213, May 2005.

8. Fung T. T. and Brown L. S., “Dietary Patterns and the Risk of Colorectal Cancer,” Curr Nutr Rep, vol. 2, no. 1, pp. 48–55, 2013.

9. Bardou M., Barkun A. N., and Martel M., “Obesity and colorectal cancer,” Gut, vol. 62, no. 6, pp. 933–947, 2013.

10. Bufill J. A., “Colorectal Cancer: Evidence for Distinct Genetic Categories Based on Proximal or Distal Tumor Location,” Ann. Intern. Med., vol. 113, no. 10, p. 779, Nov. 1990.

11. Koo J. H., Bin J., Wong S. K., Kneebone A., Connor S. J., and Leong R. W., “Improved survival in young women with colorectal cancer,” Am. J. Gastroenterol., vol. 103, no. 6, pp. 1488–1495, 2008.

12. Koo J. H. and Leong R. W., “Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer,” J. Gastroenterol. Hepatol., vol. 25, no. 1, pp. 33–42, Jan. 2010.

13. Lieberman D. A. et al., “Race, ethnicity, and sex affect risk for polyps &gt;9 mm in average-risk individuals.,” Gastroenterology, vol. 147, no. 2, pp. 351–8; quiz e14–5, Aug. 2014.

14. Douaiher J., Ravipati A., Grams B., Chowdhury S., Alatise O., and Are C., “Colorectal cancer-global burden, trends, and geographical variations,” J. Surg. Oncol., vol. 115, no. 5, pp. 619–630, Apr. 2017.

15. Jacobs E. T., Thompson P. A., and Martinez M. E., “Diet, Gender, and Colorectal Neoplasia,” J. Clin. Gastroenterol., vol. 41, no. 8, pp. 731–746, Sep. 2007.

16. Missiaglia E. et al., “Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features,” Ann. Oncol., vol. 25, no. 10, pp. 1995–2001, Oct. 2014.

17. Markowitz S. D. and Bertagnolli M. M., “Molecular origins of cancer: Molecular basis of colorectal cancer,” N. Engl. J. Med., vol. 361, no. 25, pp. 2449–2460, Dec. 2009.

18. Benedix F. et al., “Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival,” Dis. Colon Rectum, vol. 53, no. 1, pp. 57–64, Jan. 2010.

19. Duffey K. J. and Popkin B. M., “Shifts in Patterns and Consumption of Beverages Between 1965 and 2002**,” Obesity, vol. 15, no. 11, pp. 2739–2747, Nov. 2007.

20. Popkin B. M., The world is fat: the fads, trends, policies, and products that are fattening the human race. New York, NY: Penguin, 2009.

21. Barquera S. et al., “Energy Intake from Beverages Is Increasing among Mexican Adolescents and Adults,” J. Nutr., vol. 138, no. 12, pp. 2454–2461, Dec. 2008.

22. U.S. Department of Health and Human Services and U.S. Department of Agriculture, “2015–2020 Dietary Guidelines for Americans,” 2015. [Online]. http://health.gov/dietaryguidelines/2015/guidelines/. [Accessed: 07-Feb-2019].

23. Singh G. M., Micha R., Khatibzadeh S., Lim S., Ezzati M., and Mozaffarian D., “Estimated Global, Regional, and National Disease Burdens Related to Sugar-Sweetened Beverage Consumption in 2010CLINICAL PERSPECTIVE,” Circulation, vol. 132, no. 8, pp. 639–666, Aug. 2015.

24. Hu F. B. and Malik V. S., “Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence.,” Physiol. Behav., vol. 100, no. 1, pp. 47–54, Apr. 2010.

25. Lauby-Secretan B., Scoccianti C., Loomis D., Grosse Y., Bianchini F., and Straif K., “Body Fatness and Cancer—Viewpoint of the IARC Working Group,” N. Engl. J. Med., vol. 375, no. 8, pp. 794–798, Aug. 2016.

26. R. M. Bostick et al., “Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States),” 1994.

27. Slattery M. L., Caan B. J., Anderson K. E., and Potter J. D., “Intake of fluids and methylxanthine-containing beverages: Association with colon cancer,” Int. J. Cancer, vol. 81, no. 2, pp. 199–204, Apr. 1999.

28. Slattery M. L., Boucher K. M., Caan B. J., Potter J. D., and Ma K.-N., “Eating Patterns and Risk of Colon Cancer,” Am. J. Epidemiol., vol. 148, no. 1, pp. 4–16, Jul. 1998.

29. Hodge A. M., Bassett J. K., Milne R. L., English D. R., and Giles G. G., “Consumption of sugar-sweetened and artificially sweetened soft drinks and risk of obesity-related cancers,” Public Health Nutr., vol. 21, no. 09, pp. 1618–1626, Jun. 2018.

30. Zhang X. et al., “Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies.,” J. Natl. Cancer Inst., vol. 102, no. 11, pp. 771–83, Jun. 2010.

31. Bernstein L. et al., “High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).,” Cancer Causes Control, vol. 13, no. 7, pp. 625–35, Sep. 2002.

32. Horn-Ross P. L. et al., “Dietary assessment in the California Teachers Study: reproducibility and validity,” Cancer Causes Control, vol. 19, no. 6, pp. 595–603, Aug. 2008.

33. Willett W. and Stampfer M. J., “Total energy intake: implications for epidemiologic analyses.,” Am. J. Epidemiol., vol. 124, no. 1, pp. 17–27, Jul. 1986.

34. Giovannucci E., “Metabolic syndrome, hyperinsulinemia, and colon cancer: a review,” Am J Clin Nutr, vol. 86, no. suppl, pp. 836S–842S, 2007.

35. Giovannucci E., “Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence,” J. Nutr., vol. 131, no. 11, pp. 3109S–3120S, Nov. 2001.

36. Fung T. T., Hu F. B., Wu K., Chiuve S. E., Fuchs C. S., and Giovannucci E., “The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer.,” Am. J. Clin. Nutr., vol. 92, no. 6, pp. 1429–35, Dec. 2010.

37. Chazelas E. et al., “Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort.,” BMJ, vol. 366, p. l2408, Jul. 2019.

38. Giovannucci E., “A framework to understand diet, physical activity, body weight, and cancer risk,” vol. 29, pp. 1–6, 2018.

39. Klement R. J. and Fink M. K., “Dietary and pharmacological modification of the insulin/ IGF-1 system: exploiting the full repertoire against cancer,” Nat. Publ. Gr., vol. 5, p. 193, 2016.

40. Chen L. et al., “Circulating C-peptide level is a predictive factor for colorectal neoplasia: evidence from the meta-analysis of prospective studies,” Cancer Causes Control, vol. 24, pp. 1837–1847, 2013.

41. Chi F., Wu R., Zeng Y., Xing R., and Liu Y., “Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis.” doi: 10.1007/s11033-012-2432-z 23269623

42. Tabung F. K. et al., “Association of dietary insulinemic potential and colorectal cancer risk in men and women,” Am J Clin Nutr, vol. 108, pp. 363–370, 2018.

43. Tabung F. K. et al., “Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle.,” Br. J. Nutr., pp. 1–12, Nov. 2016.

44. Kit B. K., Fakhouri T. H., Park S., Nielsen S. J., and Ogden C. L., “Trends in sugar-sweetened beverage consumption among youth and adults in the United States: 1999–2010,” Am. J. Clin. Nutr., vol. 98, no. 1, pp. 180–188, Jul. 2013.

45. Bleich S. N., Vercammen K. A., Koma J. W., and Li Z., “Trends in beverage consumption among children and adults, 2003–2014,” Obesity, vol. 26, no. 2, pp. 432–441, Feb. 2018.


Článek vyšel v časopise

PLOS One


2019 Číslo 10

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Léčba bolesti v ordinaci praktického lékaře
nový kurz
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se